Market Cap (In TWD)
1.18 Billion
Revenue (In TWD)
125.26 Million
Net Income (In TWD)
-51.59 Million
Avg. Volume
14.6 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 82.7-134.0
- PE
- -25.96
- EPS
- -3.22
- Beta Value
- -0.042
- ISIN
- TW0006847007
- CUSIP
- -
- CIK
- -
- Shares
- 14230000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Dr. Luke Chen
- Employee Count
- -
- Website
- https://www.puriblood.com
- Ipo Date
- 2021-11-05
- Details
- Puriblood Medical Co., Ltd. develops and sells blood cell separation products in Taiwan. The company offers leukocyte reduction filters for red blood cells, platelets, and whole blood, as well as real-time filtration sets for whole blood. It also offers Devin blood fractionation membrane filters and Minipuri cell screening syringe filters. In addition, the company develops P-Tex Technology, which is composed by bio-inspired molecular formula zwitterionic copolymer structure. Puriblood Medical Co., Ltd. was founded in 2016 and is based in Hsinchu City, Taiwan.
More Stocks
-
ARAD
-
108230TOPTEC Co., Ltd
108230
-
COR
-
CTTCettire Limited
CTT
-
CPS
-
DRKTYDarktrace plc
DRKTY
-
BRKHW
-
6579